Medical Microbiology articles for China

Time frame: 1 July 2025 - 30 June 2026

View topic

Count: 205

Article ‘Count’ for Medical Microbiology.

Journal Count Share
10 9.12
Asymmetrically Coordinated Cu Single-Atom Nanozyme to Accelerate Inflammation and Immune Homeostasis Modulation in Acute Myocardial Infarction 1.00
Photoactivated Digital Recombinase Polymerase Amplification/CRISPR-Cas12a Assay for Point-of-Care of BK Polyomavirus Quantification 1.00
Living Cell-Metal Cyborg Microalgae for Treating MRSA Infection 1.00
An Inorganic Stimulator of Interferon Genes Sensitizer for the Metalloimmunotherapy of Intracellular Bacterial Infections 1.00
Engineering Smart Bimetallic Ionic-Site MOF Nanozyme Nanocomposites for Microenvironment-Responsive Dynamic Therapy of Periapical Periodontitis 1.00
Dual-Functional Magnesium-Doped Zeolitic Imidazolate Framework-8 Nanoparticles for Rice Blast Control and Restoration of Magnesium-Deficient Photosynthesis 0.95
Selenium-Containing Nanoscale Hydrogen-Bonded Organic Framework Nanozymes for Multienzyme Cascade Antioxidant-Targeted Therapy of Cerebral Ischemia–Reperfusion Injury 1.00
Enhanced Antibacterial Efficacy of Copper Single-Atom Catalysts on a Two-Dimensional Boron Nitride Platform 0.83
A Dual-Functional Prodrug for Imaging and Eradication of Drug-Resistant Gram-Negative Bacteria 0.33
Nanoflower-Mediated Gallium-Protoporphyrin IX Complex for Intracellular Antibacterial and Immunomodulatory Effects in Macrophage-Targeted Therapy 1.00
2 1.97
Hydrophilic Cationic Surface Modification Confers Simultaneous Antibacterial and Antithrombotic Properties to Blood-Contacting Devices 1.00
A dysregulated hepcidin-iron axis impairs antiviral immunity and induces lethal liver pathology in neonates 0.97
6 5.17
Hijacking of Bacterial ABC Transporters by DNA Nanodelivery System to Achieve Synergistic Antibacterial and Tissue Repair 1.00
Scalable Cationic-Polyurea Adhesive Engineering Enabling Glass-Fiber HEPA Filters with Mechanically Robust, High-Efficiency Microbial Capture and Rapid Inactivation 1.00
Elesclomol-Loaded Cuprous Oxide Nanozymes with Dual-Enzyme Activities for Implant-Related Infection Therapy by Enhancing Bacterial Cuproptosis-Like Death 1.00
Programmable DNA-Peptide Hybrid Nanostructures for Potent Neutralization of Multiple Influenza a Virus Subtypes 0.17
A Self‐Assembled RSV‐DS2 Based Nanovaccine Elicits a Strong Immune Response Against Respiratory Syncytial Virus Infection 1.00
NIR Light-Controlled Cascade Regulation of Mixed-Valence Copper (I)/(II) Nanozyme (Cu2−xSe) Spray for Infectious Wound Healing 1.00
5 4.75
Aminotetrazole–Gold Nanocomplexes Shunt Electrons to Eradicate Bacteria Without ROS-Induced Resistance 1.00
Biodegradable Nanospray for Sunlight-Activated Photodynamic Antibacterial Therapy and Wound Healing 0.75
Solution‐Processed Flexible Glass‐Like Antibacterial Nanocomposite Coatings 1.00
Precise Strain Tuning of PtPdRhNi Nanozyme Boosts Multi‐Pathogen and Multi‐Model Antibacterial Therapy 1.00
Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein–Barr Virus 1.00
1 1.00
Enhancement of TNFα-mediated hepatic apoptosis and liver injury by Hepatitis B virus surface antigen 1.00
3 3.00
Recombinant Phage Tail Fiber Protein Gp47 Enables Broad-Spectrum Fluorescent Detection of Pseudomonas aeruginosa Strains 1.00
Preparation, Characterization, and Binding Mechanism of Nanobodies Targeting Multiple Serotypes of Salmonella 1.00
Galactose Unit-Based Liposomal Nanoprobes for Pseudomonas aeruginosa Targeting Imaging and In Situ Antibacterial Therapy 1.00
2 2.00
Chemical Synthesis and Immunological Evaluation of Escherichia coli O29, Shigella dysenteriae Serotype 11, and Proteus vulgaris O12 O-Antigen Oligosaccharides 1.00
Deep Learning-Enhanced DNAzyme-Driven Rolling-Circle Amplification Encoding for Multibacterial Detection 1.00
7 4.76
Scavenger receptor class F member 2 is an intracellular receptor for hepatitis B virus 0.87
Virological characteristics of SARS-CoV-2-related coronaviruses dynamically circulating in Southeast Asia 0.07
Differential inhibition of Morbillivirus and Henipavirus polymerases by ERDRP-0519 and structure-guided inhibitor optimization 0.90
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation 0.27
Molecular characterization of Ebola virus glycoprotein V75A substitution in the 2018–2020 epidemic 1.00
Extensive cross-species transmission of pathogens and antibiotic resistance genes in mammals neglected by public health surveillance 0.66
Structurally conserved human anti-A35 antibodies protect mice and macaques from mpox virus infection 1.00
1 0.92
A conserved adaptor orchestrates co-secretion of synergistic type VI effectors in gut Bacteroidota 0.92
2 2.00
Coordination-driven supramolecular metalla-cycles/cages for next-generation antibacterial therapy 1.00
SsrA-based design of BacPROTACs for β-lactamase degradation in Gram-negative bacteria 1.00
3 2.19
Near-point-of-care diagnosis of tuberculosis with LyocartE MTB Assay: a multicentre diagnostic accuracy study 1.00
Fatal Case of Human B Virus Infection Manifesting with Hemorrhagic Encephalitis and Chorioretinitis 1.00
Development and Clinical Evaluation of a Novel Talaromyces marneffei Mp1p Lateral Flow Assay for Rapid Diagnosis of Talaromycosis 0.19
2 2.00
Enterococcus is a potential reservoir associated with antibiotic resistance in the “environment-animal-human” chain of dairy farms: evidence from ecological linkage 1.00
Pulmonary toxicity and antibiotic resistance risks induced by environmental MRSA exposure in mice 1.00
1 1.00
Context-informed tracing of blaNDM-1 and chromosomal blaOXA-48 in Shewanella xiamenensis: defining the clinical node within the wastewater-patient continuum 1.00
2 1.80
Integrative Phenotypic and Genotypic Surveillance and Risk Assessment of Foodborne Antimicrobial Resistance in Meat–Environment Continuum 0.80
Exposure to Environmentally Relevant Concentrations of Antibiotics Increases N2O Emissions and Delays Nitrate Removal: New Insights into Bacteriostatic Antibiotics at the Cellular Level 1.00
1 0.96
Vonoprazan–tetracycline dual regimen as rescue therapy for Helicobacter pylori infection: randomized controlled trial 0.96
1 1.00
Long-read sequencing reveals HBV integration patterns and oncogenic impact on early-onset hepatocellular carcinoma 1.00
10 7.41
Functional anti-preS1 antibody responses associated with viral control in chronic hepatitis B 0.93
Nucleotide analogue bemnifosbuvir inhibits hepatitis E virus replication in preclinical models 0.24
Twenty-four-week anti-PD-1 antibody regimen promoted HBsAg reduction and concurrently enhanced HBV-specific T cell responses in patients with chronic hepatitis B 1.00
Engineered virus-hunter vaccine overcomes HBV immune tolerance 1.00
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER) 0.21
EASL 2025 indications revisited: phase-specific outcomes with and without nucleos(t)ide analogue therapy in chronic hepatitis B virus infection 1.00
iPSC-induced multilineage liver organoids, small intestinal organoids and brain organoids sustain pangenotype hepatitis E virus propagation 1.00
Large-scale profile study on hepatitis B surface antigen levels in chronic hepatitis B: implications for drug development targeting functional cure 1.00
Therapeutic inhibition of HBsAg and HBV cccDNA through a novel phased combination treatment: glycine and interferon-α 1.00
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions 0.03
2 2.00
HBsAg seroclearance further reduces hepatocellular carcinoma but not hepatic decompensation in patients with cirrhosis and complete viral suppression. 1.00
Host-viral interaction of HBV infection revealed by single-cell transcriptome jointly profiling the viral replication state. 1.00
6 4.76
Hepatitis B virus promotes hepatocellular carcinogenesis by activating IL-6-dependent tumor-macrophage crosstalk and M2-like macrophage polarization 1.00
Structural insights into histone mimicry by the small hepatitis delta antigen 1.00
Molecular mechanism of 2′,3′-cGAMP degradation by monkeypox virus poxin-schlafen protein 1.00
Pharmacological targeting of the mycothiol cysteine ligase MshC in Mycobacterium abscessus 0.13
A Pseudomonas aeruginosa endolytic muramidase targets cell-wall peptidoglycan in bacterial competition 0.64
Modeling Mycobacterium tuberculosis Pathogenesis in Lung Epithelial Organoids Reveals Strain-Specific Host Responses and Intercellular Crosstalk 1.00
1 1.00
Targeting the host factor HGS-viral membrane protein interaction in coronavirus infection 1.00
5 2.65
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B – follow-up from the RETRACT-B cohort 0.12
A genome-wide siRNA screen identifies previously unknown proviral and antiviral host factors in HBV infection 0.50
HBx-induced HSPB1 is a potential therapeutic target owing to its modulation of HBV cccDNA and hepatic immune responses 1.00
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells 0.03
Enhanced surveillance, subtyping, and host adaptation analysis reveal genotype-wide zoonotic potential of rat hepatitis E virus 1.00
11 10.93
Correlates of human Cytomegalovirus Cervical Shedding in Seropositive Women: Implications for Vaccine Development 1.00
Single-cell RNA sequencing reveals mucosal BPIFA1-high-expressing neutrophils aid immune defense in SARS-CoV-2 breakthrough infection 1.00
Unnoticed Entry, Noticed Transmission: Epidemiological Insights into China’s First clade Ib MPXV cluster 1.00
Characterization of bronchiolitis and vaccine-induced enhanced respiratory disease in Syrian hamsters caused by respiratory syncytial virus infection 1.00
Severe Lower Respiratory Tract Infection in Patients With Human Bocavirus Monoinfection in Southeast China 0.93
Decoding Hypervirulence in Carbapenem-Resistant Klebsiella pneumoniae: Genomic and Phenotypic Profiling Reveals Capsular Polysaccharide as a Key Driver of Pathogenicity 1.00
Comparative Analysis of High-Dose Dual Therapies in First-Line Helicobacter pylori Eradication: An Inverse Probability of Treatment-Weighted Multicenter Study 1.00
Rhinovirus-associated lower respiratory tract infection in hospitalized adult patients: a retrospective cohort study 1.00
<atl>iBartonella henselae/i Subverts Host Cell Apoptosis by Linking Intracellular NOD2 Sensing to an AREG/EGFR Autocrine Survival Loop</atl> 1.00
Phospholipid transporter MlaFEDCB regulates iKlebsiella pneumoniae/i virulence by modulating fimbriae synthesis and stress-adaptive growth 1.00
Prognostic Divergence in Human Immunodeficiency Virus/Hepatitis B Virus Versus Hepatitis B Virus–Associated Hepatocellular Carcinoma After Resection: Intrahepatic Pre-S Deletions Mutants and T-Cell Depletion Under Viral Suppression 1.00
3 3.00
Microenvironment Magnesium Overload Disrupts Bacterial Membrane Functions for the Central Nervous System Infection Treatment 1.00
Inorganic Antibody-Mimetic H‑Zeolite Blocks Airborne Viruses via E340-Targeted Biorecognition 1.00
Inhibitor-Dependent Tolerance of New Delhi Metallo-β-Lactamase Driven by Single Mutation-Induced Conformational Changes 1.00
1 1.00
The DdmDE defense system eradicates plasmids by target-centered bidirectional ssDNA loop extrusion and site-specific cleavage 1.00
3 1.97
Highly Efficient Broad-Spectrum Antibacterial Carbon Dots through Hierarchical Machine Learning Framework 1.00
CuInP2S6 Captures Virus for Viral Inhibition and Vaccine Adjuvanticity 0.82
Silver-Loaded Titania-Based Metal–Organic Frameworks as a Platform for Silver Ion Release for Antibacterial Applications 0.14
2 0.88
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk 0.84
SuFEx-based antitubercular compound irreversibly inhibits Pks13 0.04
73 65.12
Enhanced invasiveness promotes the dominance of a widely-distributed carbapenem-resistant virulence-plasmid-carrying Klebsiella pneumoniae sublineage 0.95
A structurally unique effector shared between vascular wilt fungi drives cotton and olive defoliation 0.12
Engineering a dual-antigen mRNA vaccine to restore immune control in chronic hepatitis B 1.00
Human angiotensin‑converting enzyme 2‑specific benzothiazole-based allosteric inhibitor against pan‑sarbecoviruses 0.96
Structural and mechanistic insights into the inhibition of Plasmodium falciparum MDR1 0.93
Long-term spatiotemporal evolution of drug-resistant Mycobacterium tuberculosis in China 0.65
Manganese enhances macrophage bactericidal activity in mice with Staphylococcus aureus osteomyelitis via Sirt3-mitophagy axis 1.00
Host mature tRNAome as a decoding switch regulates antiviral and proviral responses 0.94
Structural basis for RNA synthesis and inhibition of the orthobunyavirus polymerase 1.00
Ultrastructural and atomic characterization of biofilm-associated extracellular filaments in Shewanella oneidensis MR-1 1.00
Nasopharyngeal carcinoma screening using Epstein–Barr virus Cp methylation triage in two population-based screening cohorts 0.86
Spatial transcriptomic atlas of murine neurotoxocariasis reveals region-specific host responses and dysfunction in the brain 0.85
Next-generation inhibitors of SARS-CoV-2 M overcome the deficiencies of Paxlovid 1.00
High-risk EBV promotes immune evasion in nasopharyngeal carcinoma by upregulating HLA-DP via the encoded BALF2-HR variant 0.98
Targeting phenol-soluble modulin α3-driven M1 macrophage polarization and necroptosis mitigates MRSA infection in mice 1.00
Copper single-atom nanozyme with intelligent capture and photo-enhanced activity for controlling plant bacterial diseases 1.00
A mouse-adapted Yezo virus model for antiviral testing in immunocompetent mice 1.00
A highly potent nanobody-based bispecific therapeutic provides broad-spectrum protection against ebolavirus 1.00
The conserved human astrovirus-receptor interface reveals a targetable vulnerability for antiviral development 1.00
Distinct genomic trajectory among invasive Salmonella Typhimurium ST313 infections 1.00
Inhibiting Mrt4-rRNA interaction with fumaramidmycin-based derivatives as an antifungal strategy 0.94
Effector conformational plasticity enables lineage-specific secretion via Hcp heterohexamers in gut symbionts 1.00
The crucial but insufficient role of E2s domain’s residues 490 and 492 in determining the host tropism of hepatitis E virus 1.00
Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants 0.92
YL1004 is a SARS-CoV-2 papain-like protease inhibitor with immunomodulatory and antiviral activity in mice 1.00
Dual-functional quorum sensing signal synthases DspII and DspI coordinate virulence switch in Pseudomonas aeruginosa 1.00
Sero-genomic evidence for occult mpox exposure in healthy Nigerian adults 0.01
Tissue-specific and sex-biased glycoproteomic landscape of 1.00
Efficacy of two rounds of albendazole treatment on soil-transmitted helminths in schoolchildren, Yunnan Province, China 0.24
Retrospective cohort study of hepatitis B immunization strategy effects in Beijing across 30 years 1.00
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study 0.82
Intervention timing and disease stage shape tecovirimat and cidofovir efficacy in male SCID mice 1.00
Molecular mechanisms of receptor recognition and antibody neutralization of coxsackievirus A6 1.00
Long-term protection from naturally acquired immunity against hepatitis E virus reinfection 1.00
Small molecule inhibitor targets OmpV to treat pandemic Vibrio cholerae infection 1.00
Increased risk of antimicrobial resistance in patients with cirrhosis and hepatic encephalopathy using rifaximin 0.14
A Pseudomonas aeruginosa quorum-sensing inducer controls lung permeability in establishing chronic infection via EGFR 1.00
Structural insights into VLDLR recognition by western equine encephalitis virus 1.00
Immune profiling of mpox survivors reveals divergent durability of antibody and T cell responses 1.00
Orphan broadly RBD-binding antibodies annotate three remaining conserved RBD epitopes along SARS-CoV-2 evolution 0.90
UHRF1 restricts HCoV-229E infection through epigenetic silencing of the viral receptor APN 1.00
Coronaviral nsp6 hijacks ERAD machinery to facilitate lipolysis and supply membrane components for DMV growth 1.00
Prognostic value of an abnormal chest X-ray result in predicting the development of tuberculosis 0.87
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study 0.89
Neutralizing antibodies against Chikungunya virus and structural elucidation of their mechanism of action 1.00
Structural insights into the secretin complex of a type IVb pilus system 1.00
Extracellular vesicles derived EBV tegument protein BRRF2 suppresses cGAS phase separation to promote anti-viral innate immune evasion 1.00
Node role of wild boars in virus circulation among wildlife and domestic animals 1.00
Epigenetically conferred ring-stage survival in against artemisinin treatment 0.72
Coordinated regulation of pH alkalinization by two transcription factors promotes fungal commensalism and pathogenicity 1.00
Serological proteomic characterization for monitoring liver fibrosis regression in chronic hepatitis B patients on treatment 1.00
The pathogenicity and multi-organ proteomic profiles of Mpox virus infection in SIVmac239-infected rhesus macaques 1.00
A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infection 1.00
Ecological connectivity of genomic markers of antimicrobial resistance in Escherichia coli in Hong Kong 0.77
RIPK1 kinase drove brain microvascular endothelial cells death and blood-brain barrier disruption in neonatal meningitis 1.00
The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized controlled trial 1.00
Tiantan vaccinia virus-based vaccine with promising safety provides sustained protection against mpox in non-human primates 1.00
Virus-human chromatin interactions reorganise 3D genome and hijack KDM5B for promoting metastasis in nasopharyngeal carcinoma 0.96
2-oxoglutarate:acceptor oxidoreductase-catalyzed redox cycling effectively targets coccoid forms of Helicobacter pylori 1.00
SARS-CoV-2 rebound and post-acute mortality and hospitalization among patients admitted with COVID-19: cohort study 0.89
Biomarkers of pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis through single-cell transcriptomics 0.95
Diversity and transmission and zoonotic potential of microbes in true insectivores 0.91
The crystal structure of coronavirus RBD-TMPRSS2 complex provides basis for the discovery of therapeutic antibodies 1.00
An orally available M/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo 1.00
Host protein ARF1 is a proviral factor for SARS-CoV-2 and a candidate broad-spectrum therapeutic target 1.00
Structural basis for engagement of Western Equine Encephalitis Virus with the PCDH10 receptor 1.00
Vesicle-associated membrane protein 5 is an intrinsic defense factor for embryonic stem cells against coronaviruses 1.00
Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants 0.13
Tracking international and regional dissemination of the KPC/NDM co-producing 1.00
Epstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China 0.94
Colistin enhances caspofungin antifungal efficacy against by modulating calcium homeostasis and stress responses 0.11
CRISPRi screen identifies FprB as a synergistic target for gallium therapy in Pseudomonas aeruginosa 0.75
Lactate promotes invasive liver abscess syndrome by increasing capsular polysaccharide biosynthesis via the PTS-CRP axis 1.00
2 1.06
Evaluation of antimicrobial resistance governance across 193 countries to inform the 2026 Global Action Plan update 0.67
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial 0.39
1 0.58
Livestock antimicrobial use embodied in global supply chains 0.58
1 1.00
A bacterial ecocline in Klebsiella pneumoniae may explain its backboned phylogeny 1.00
1 0.92
Genomic profiling and experimental validation of type VI secretion system-associated proteins in Klebsiella. 0.92
20 15.60
Genomic and structural evidence of SARS-CoV-2 and MERS-CoV in migratory birds 1.00
Cryo-EM structures of Měnglà virus GP reveal combined Ebola- and Marburg-like epitope masking strategies for antibody evasion 1.00
TadA-mediated A-to-I mRNA editing rewires redox metabolism to promote dominance of epidemic Klebsiella pneumoniae clones 1.00
Multivalent mRNA vaccine platform with compatible antigens conferred broad-spectrum protection against orthoebolaviruses’ exposure 1.00
The low-density lipoprotein receptor LDLR mediates cellular entry of nonenveloped hepatitis A virus 0.08
The SMARCA4–TMEM47 axis plays an essential role in chikungunya virus RNA replication 1.00
EIF4H and YBX1 are essential host factors for hepatitis E virus replication and pathogenesis 0.69
Cryo-EM structure of locked spike glycoprotein from bat SARS-like coronavirus WIV1, molecular dynamics and biophysics across host range 0.50
Decoding antibody response to MERS-CoV in wild dromedary camels 0.70
Structural basis of mpox virus A30/H2 subcomplex formation 1.00
SARS-CoV-2 S assembly into virions facilitated by host ERM proteins 1.00
SARS-CoV-2 peptide fragments selectively dysregulate specific immune cell populations via Gaussian curvature targeting 0.24
Glycosylation of GETV E2 promotes pathogenesis in animal models 1.00
The prion-like characteristic of ORF3 contributes to virion release and pathogenesis of hepatitis E virus 0.94
Origin and adaptive evolutionary trajectory of the 3′ UTR–derived sRNA UhpU in Enterobacteriaceae 1.00
Flagellar location determines the stability of bacterial surface entrapment 1.00
A nonenzymatic effector disrupts Bacteroides cell wall homeostasis via OmpA targeting to mediate interbacterial competition 0.93
Fatty acid 2-hydroxylase facilitates rotavirus uncoating and endosomal escape 0.21
Tat-dependent bundling pilus of a halophilic archaeon assembles by a strand donation mechanism and facilitates biofilm formation 0.38
A granulin-positive macrophage subtype in mycobacterial granulomas alleviates tissue damage by limiting excessive inflammation 0.95
3 2.17
RTX-family toxin EhxA drives morphological remodeling and thrombogenesis in RBCs during enterohemorrhagic Escherichia coli infection 0.17
Chemically tailored anionic antibiotic adjuvants targeting divalent cations to overcome carbapenem resistance in gram-negative bacteria 1.00
Structures and receptor binding activities of merbecovirus spike proteins reveal key signatures for human DPP4 adaptation 1.00
3 2.16
Antibody cocktails based on the occupationally acquired immunity of pediatricians neutralize and confer protection against RSV and hMPV 1.00
An antibody cocktail targeting conserved, nonoverlapping epitopes prevents viral escape and confers protection against RSV in vivo 1.00
Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesions 0.16
1 1.00
Disruption of ER-mitochondria contact sites by coronavirus replication organelles sustains viral replication via NSP3 stabilization 1.00
1 1.00
Microwave-Assisted In Situ Encapsulation of Uniform Ag Nanoclusters in ZSM-5 for Enhanced Catalytic and Antibacterial Performance 1.00
1 0.60
Regional and type-specific variations in the global seasonality of human parainfluenza viruses and the influence of climatic factors: a systematic review and meta-analysis 0.60
2 0.19
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection 0.15
Clesrovimab for Prevention of RSV Disease in Healthy Infants 0.04
1 0.92
Sec62 restricts ER-replicating positive-strand RNA virus infections via UPR-dependent ER-phagy 0.92
1 1.00
Enhanced diagnosis of tuberculous pleurisy using a multiplex droplet digital PCR assay targeting circulating mycobacterial DNA 1.00
1 1.00
UV-Induced VBNC state formation and resuscitation in E. coli: ATP-based metabolic activation and biofilm-mediated recovery 1.00

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.